FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
latest-news-card-1
Medical Devices

Medtronic Recalls DLP Left Heart Vent Catheters

Medtronic Perfusion Systems recalls (Class 1) its DLP Left Heart Vent Catheters (malleable body and vented connector) because the devices may not reta...

Human Drugs

FDA Posts Alopecia Complex Case Study

FDA posts a drug complex innovative design case study for a higher dose of an alopecia areata drug that did not assign participants to a separate plac...

latest-news-card-1
Human Drugs

CGMP Violations at Amneal Gujarat, India

FDA warns Amneal Pharmaceuticals about CGMP violations in its Gujarat, India, drug manufacturing facility.

FDA General

FDA, CDC Staff Pen Open Letter to Remove RFK Jr.

Over a thousand current and former staff at FDA, CDC, and NIH pen a new open letter to HHS secretary Robert F. Kennedy Jr. and Congress, calling for K...

Biologics

Prasad Has Covid YouTube Videos Pulled

The Guardian says CBER director Vinay Prasad successfully had videos of him criticizing Covid vaccines removed from the YouTube channel of a physician...

latest-news-card-1
Human Drugs

Boehringer Gets Breakthrough Status for Hernexeos

FDA grants Boehringer Ingelheim a breakthrough therapy designation for Hernexeos (zongertinib) tablets for the first-line treatment of certain adults ...

Human Drugs

FDA Rare Disease Evidence Principles

CDER and CBER launch the Rare Disease Evidence Principles process intended to bring greater speed and predictability to the review of rare disease the...

Biologics

CBER Raising Bar on Future Covid Vaccines

Memos posted on FDAs Web site from CBER director Vinay Prasad suggest the agency is raising the bar on future Covid-19 vaccination approvals.

latest-news-card-1
Human Drugs

FDA Accepts NDA for Smoking Cessation Drug

FDA accepts for review an Achieve Life Sciences NDA for cytisinicline, an investigational treatment for helping those seeking to quit smoking.

latest-news-card-1
Human Drugs

AI Can Cut Drug Development Costs, Time: Experts

Reuters reports that drug manufacturers are turning to artificial intelligence to reduce animal testing and cut costs and time in drug development.